A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals-Reference-Cited by-同舟云学术

A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals

Published:2012-01-19 Issue:7 Volume:54 Page:946-954
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Ehrlich H. J.,Singer J.,Berezuk G.,Fritsch S.,Aichinger G.,Hart M. K.,El-Amin W.,Portsmouth D.,Kistner O.,Barrett P. N.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/54/7/946/845613/cir959.pdf

Reference32 articles.

1. Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

2. Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults

3. Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines

4. Efficacy of Inactivated Split‐Virus Influenza Vaccine against Culture‐Confirmed Influenza in Healthy Adults: A Prospective, Randomized, Placebo‐Controlled Trial

5. Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vaccines

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus‐associated disease in breakthrough infections in adults ≥60 years of age;Influenza and Other Respiratory Viruses;2024-02

2. Systematic review of the efficacy, effectiveness and safety of cell‐based seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age;Reviews in Medical Virology;2022-02-08

3. Patient-reported outcomes in vaccines research: relevance for decision-making;Human Vaccines & Immunotherapeutics;2021-02-19

4. Burden‐of‐illness vaccine efficacy;Pharmaceutical Statistics;2020-03-27

5. Challenges in the development of egg-independent vaccines for influenza;Expert Review of Vaccines;2019-07-03